Global Public Interest in Prostate Cancer Imaging: A Google Trends Analysis of PSMA PET and Conventional Modalities (2010–2025)
Abstract
Purpose: This study evaluates and compares global public interest in Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) imaging with traditional prostate cancer imaging modalities using Google Trends data from 2010 to 2025, and analyzes how digital engagement aligns with key clinical milestones.
Methods: This observational infodemiology study analyzed Google Trends data for four search terms: 'PSMA PET Scan', 'MRI Prostate Cancer', 'Bone Scan Prostate Cancer', and 'Prostate Cancer Scan' from January 2010 to April 2025. Average interest scores were calculated for pre- and post-milestone periods. Linear regression estimated PSMA PET growth rates post-2020, and milestone-aligned surge analysis quantified changes surrounding key clinical events including the proPSMA trial publication, FDA approval, and guideline updates.
Results: PSMA PET search interest increased dramatically after March 2020, with sustained monthly growth (R²=0.87). By 2023, PSMA PET interest surpassed bone scan levels and approached MRI interest. FDA approval of Gallium-68 PSMA-11 generated the strongest public response, while guideline updates showed minimal immediate impact. Overall average interest rankings were: Prostate Cancer Scan (44.9), MRI Prostate Cancer (40.8), PSMA PET Scan (20.6), and Bone Scan Prostate Cancer (13.7).
Conclusion: PSMA PET has rapidly captured public interest parallel to its clinical validation and regulatory approval, reflecting growing importance in prostate cancer imaging. Infodemiology approaches provide valuable insights into medical innovation ad3option and assist stakeholders in anticipating trends and developing health policies in molecular imaging.
Keywords
References
- 1. Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395:1208– 16. DOI:10.1016/S0140-6736(20)30314-7
- 2. Fendler WP, Calais J, Eiber M, et al. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial. JAMA Oncol. 2019;5:856–63. DOI:10.1001/ jamaoncol.2019.0096
- 3. Zhao G, Ji B. Head-to-head comparison of 68Ga-PSMA-11 PET/ CT and 99mTc-MDP bone scintigraphy for the detection of bone metastases in patients with prostate cancer: a meta-analysis. AJR Am J Roentgenol. 2022;219:386–95. DOI:10.2214/AJR.21.27323
- 4. Holzgreve A, Armstrong WR, Clark KJ, et al. PSMA-PET/CT findings in patients with high-risk biochemically recurrent prostate cancer with no metastatic disease by conventional imaging. JAMA Netw Open. 2025;8:e2452971. DOI:10.1001/jamanetworkopen.2024.52971
- 5. Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTROESUR- SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79:243–62. DOI:10.1016/j.eururo.2020.09.042
- 6. Eysenbach G. Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the internet. J Med Internet Res. 2009;11:e11. DOI:10.2196/jmir.1157
- 7. Mavragani A, Ochoa G. Google Trends in infodemiology and infoveillance: methodology framework. JMIR Public Health Surveill. 2019;5:e13439. DOI:10.2196/13439
- 8. Nuti SV, Wayda B, Ranasinghe I, et al. The use of Google Trends in health care research: a systematic review. PLoS One. 2014;9:e109583. DOI:10.1371/journal.pone.0109583
Details
Primary Language
English
Subjects
Primary Health Care
Journal Section
Research Article
Publication Date
January 16, 2026
Submission Date
May 29, 2025
Acceptance Date
October 23, 2025
Published in Issue
Year 2026 Volume: 17 Number: January, February, March 2026